- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.06. | Bullion Gold Resources Corp (2): Bullion Gold acquisition of Cadillac extension project | 2 | Stockwatch | ||
| 19.06. | Bullion Gold Resources Corp (2): Bullion Gold closes Cadillac Extension acquisition | 1 | Stockwatch | ||
| 18.06. | Bullion Gold Resources Corporation: Bullion Gold Completes the Acquisition of the Cadillac Extension (Langlade) Project | 428 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 18, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to announce that it has closed the transaction to acquire... ► Artikel lesen | |
| 05.06. | Bullion Gold Resources Corp (2): Bullion Gold Resources private placement | 1 | Stockwatch | ||
| 05.06. | Bullion Gold Resources Corp (2): Bullion Gold private placement | 1 | Stockwatch | ||
| 03.06. | Bullion Gold Resources Corporation: Bullion Gold Begins Exploration Work on Bodo | 646 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 3, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to announce the imminent launch of a second exploration program... ► Artikel lesen | |
| BULLION GOLD RESOURCES Aktie jetzt für 0€ handeln | |||||
| 09.05. | Bullion Gold Resources Corp (2): Bullion Gold signs LOI for Cadillac Extension project | 1 | Stockwatch | ||
| 08.05. | Bullion Gold Resources Corporation: Bullion Gold Acquires the Cadillac Extension (Langlade) Project | 216 | Newsfile | Montreal, Quebec--(Newsfile Corp. - May 8, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to announce the signing of a letter of intent to acquire 100%... ► Artikel lesen | |
| 04.04. | Bullion Gold Resources Corp (2): Bullion receives TSX-V approval for Bousquet option | 1 | Stockwatch | ||
| 04.04. | Bullion Gold Resources Corporation: Bullion Gold Completes Transaction on Bousquet Property with Olympio Metals and Closes Financing | 1.657 | Newsfile | Montreal, Quebec--(Newsfile Corp. - April 4, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "the Company") announces that the option agreement on the Bousquet property with Olympio... ► Artikel lesen | |
| 28.03. | Bullion Gold Resources Corp (2): Bullion Gold sale of option for Bousquet | 1 | Stockwatch | ||
| 18.03. | Bullion Gold Resources Corp (2): Bullion Gold signs option agreement with Olympio | 1 | Stockwatch | ||
| 18.03. | Bullion Gold Resources Corporation: Bullion Gold Signs Option Agreement with Olympio Metals for the Bousquet Project | 481 | Newsfile | Montreal, Quebec--(Newsfile Corp. - March 18, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "the Company") announces the signing of an option agreement with Olympio Metals ("Olympio"... ► Artikel lesen | |
| 25.02. | Bullion Gold Resources Corp (2): Bullion Gold grants option to sell 80 per cent of Bousquet | 1 | Stockwatch | ||
| 25.02. | Bullion Gold Resources Corporation: Bullion Gold Grants Option on Its Bousquet Project to Olympio Metals | 544 | Newsfile | Montreal, Quebec--(Newsfile Corp. - February 24, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "the Company") announces the signing of a letter of intent with Olympio Metals (ASX:... ► Artikel lesen | |
| 14.01. | Bullion Gold Resources Corp (2): Bullion Gold appoints Morissette as president, CEO | 1 | Stockwatch | ||
| 14.01. | Bullion Gold Resources Corporation: Morissette Joins Bullion Gold to Develop the Bodo Project | 730 | Newsfile | Montreal, Quebec--(Newsfile Corp. - January 14, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "the Company") announces the appointment of Mr. Guy Morissette as President and Chief... ► Artikel lesen | |
| 03.01. | Bullion Gold Resources Corp (2): Bullion Gold closes $448,450 private placement | 1 | Stockwatch | ||
| 03.01. | Bullion Gold Resources Corporation: Bullion Gold Completes Private Placement | 3.404 | Newsfile | Montréal, Québec--(Newsfile Corp. - January 3, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Corporation") announces that it has closed a private placement (the "Offering")... ► Artikel lesen | |
| 04.12.24 | Bullion Gold Resources Corporation: Moore and Gervais Appointed Directors of Bullion Gold Resources | 921 | Newsfile | Montreal, Quebec--(Newsfile Corp. - December 4, 2024) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to announce the appointments of MM. Jean-David Moore and... ► Artikel lesen |
1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SPRINGWORKS THERAPEUTICS | 47,005 | 0,00 % | SpringWorks Therapeutics, Inc. - 8-K, Current Report | ||
| VERA THERAPEUTICS | 23,560 | 0,00 % | Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | BRISBANE, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on June 3, 2025, the Compensation Committee granted inducement awards consisting of... ► Artikel lesen | |
| ARTELO BIOSCIENCES | 13,180 | 0,00 % | Artelo Biosciences Announces Positive First-in-Human Data for ART26.12, a Novel Non-Opioid Treatment Candidate for Persistent Pain | First Orally Active Fatty Acid Binding Protein 5 Inhibitor Evaluated in Humans First-in-Class Approach Targets Unmet Need in Multibillion-Dollar Pain Management Market SOLANA BEACH, Calif., June 30... ► Artikel lesen | |
| PRAXIS PRECISION MEDICINES | 42,050 | 0,00 % | Praxis Precision Medicines, Inc. - 8-K, Current Report | ||
| ADMA BIOLOGICS | 18,190 | 0,00 % | Will Strong Asceniv Sales Drive ADMA Biologics Further? | ||
| NURIX THERAPEUTICS | 11,390 | 0,00 % | Nurix Therapeutics, Inc.: Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | SAN FRANCISCO, June 13, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of... ► Artikel lesen | |
| RECURSION PHARMACEUTICALS | 5,050 | 0,00 % | Recursion Pharmaceuticals: Recursion Reports First Quarter 2025 Financial Results and Provides Business Update | Pipeline: Delivered on our commitment to a more focused R&D strategy by advancing a streamlined portfolio of 5+ clinical and preclinical programs in oncology and rare disease, while deprioritizing... ► Artikel lesen | |
| TANGO THERAPEUTICS | 5,120 | 0,00 % | Tango Therapeutics, Inc.: Tango Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of TNG462 plus Revolution Medicines' Daraxonrasib or Zoldonrasib in Patients with RAS-Mutant MTAP-deleted Pancreatic or Lung ... | BOSTON, June 27, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering the next generation of precision cancer medicines... ► Artikel lesen | |
| EVOTEC | 7,120 | -1,17 % | EQS-News: Evotec SE: Evotecs Partnerschaft mit dem NURTuRE-AKI Konsortium ermöglicht innovative therapeutische Ansätze basierend auf molekularem Verständnis von akutem Nierenversagen | EQS-News: Evotec SE
/ Schlagwort(e): Sonstiges
Evotecs Partnerschaft mit dem NURTuRE-AKI Konsortium ermöglicht innovative therapeutische Ansätze basierend auf molekularem Verständnis... ► Artikel lesen | |
| QIAGEN | 40,585 | -0,73 % | Minimale Kursveränderung bei Qiagen NV-Aktie (40,55 €) | Am Aktienmarkt ist der Anteilsschein von Qiagen NV gegenwärtig unauffällig. Das Wertpapier kostete zuletzt 40,55 Euro. Der heutige Börsentag brachte bislang wenig Kursbewegung bei der Aktie von Qiagen... ► Artikel lesen | |
| APOGEE THERAPEUTICS | 43,490 | 0,00 % | Apogee Therapeutics Provides Business Update, Pipeline Progress and Reports First Quarter 2025 Financial Results | Phase 2 APEX trial of APG777 in atopic dermatitis advancing with interim Part A 16-week data expected in mid-2025 and Part B actively enrolling First patient dosed in Phase 1b trial of APG777 in... ► Artikel lesen | |
| CELCUITY | 13,350 | 0,00 % | Celcuity Inc.: Celcuity Reports Clinical Data from Two Early Phase Studies of Gedatolisib | • In the Phase 1 portion of the CELC-G-201 clinical trial evaluating gedatolisib plusdarolutamide in men with metastatic castration resistant prostate cancer ("mCRPC"),the six-month radiographic progression... ► Artikel lesen | |
| VOR BIOPHARMA | 1,610 | 0,00 % | Pre-market Movers: Vor Biopharma, Worthington Steel, Surf Air Mobility, Nano Labs, Protagenic Therapeutics | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.30 A.M. ET).In the Green Vor Biopharma Inc. (VOR) is up over 109% at $1.16.
Worthington... ► Artikel lesen | |
| SUMMIT THERAPEUTICS | 21,250 | 0,00 % | Revolution Medicines, Inc.: Revolution Medicines and Summit Therapeutics Enter into Clinical Collaboration to Evaluate Combinations of Three RAS(ON) Inhibitors with Ivonescimab in RAS Mutant Tumors | REDWOOD CITY, Calif. and MIAMI, June 30, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with... ► Artikel lesen | |
| QUANTUM-SI | 1,960 | 0,00 % | Quantum-Si Incorporated: Quantum-Si Showcases Advances in Multiomics at the Festival of Genomics UK | Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company, announces its participation in the upcoming Festival of Genomics UK, taking place on... ► Artikel lesen |
BULLION GOLD RESOURCES CORPORATION gehört der Branche Biotechnologie an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BULLION GOLD RESOURCES CORPORATION finden Sie auf Wallstreet Online.